Stem cell transplants into spinal cord lesions may help to improve regeneration and spinal cord function. Clinical studies are necessary for transferring preclinical findings from animal experiments to humans. We investigated the transplantation of unmanipulated autologous bone marrow in patients with transversal spinal cord injury (SCI) with respect to safety, therapeutic time window, implantation strategy, method of administration, and functional improvement. We report data from 20 patients with complete SCI who received transplants 10 to 467 days postinjury. The follow-up examinations were done at 3, 6, and 12 months after implantation by two independent neurologists using standard neurological classification of SCI, including the ASIA protocol, the Frankel score, the recording of motor and somatosensory evoked potentials, and MRI evaluation of lesion size. We compared intra-arterial (via catheterization of a. vertebralis) versus intravenous administration of all mononuclear cells in groups of acute (10-30 days post-SCI, n=7) and chronic patients (2-17 months postinjury, n=13). Improvement in motor and/or sensory functions was observed within 3 months in 5 of 6 patients with intra-arterial application, in 5 of 7 acute, and in 1 of 13 chronic patients. Our case study shows that the implantation of autologous bone marrow cells appears to be safe, as there have been no complications following implantation to date (11 patients followed up for more than 2 years), but longer follow-ups are required to determine that implantation is definitively safe. Also, we cannot yet confirm that the observed beneficial effects were due to the cell therapy. However, the outcomes following transplantation in acute patients, and in one chronic patient who was in stable condition for several months prior to cell implantation, are promising. It is evident that transplantation within a therapeutic window of 3-4 weeks following injury will play an important role in any type of stem cell SCI treatment. Trials involving a larger population of patients and different cell types are needed before further conclusions can be drawn.

Center for Cell Therapy and Tissue Repair Charles University Prague Czech Republic

Department of Imaging Methods University Hospital Motol and 2nd Medical Faculty Charles University Prague Czech Republic

Department of Neurology University Hospital Motol and 2nd Medical Faculty Charles University Prague Czech Republic

Department of Pediatric Hematology and Oncology University Hospital Motol and 2nd Medical Faculty Charles University Prague Czech Republic

Department of Spondylosurgery University Hospital Motol Prague Czech Republic

Institute of Experimental Medicine ASCR Prague Czech Republic

Institute of Hematology and Blood Transfusion Prague Czech Republic

Literatura

000      

00000naa a2200000 a 4500

001      

bmc13033204

003      

CZ-PrNML

005      

20131015151249.0

007      

ta

008      

131014s2006 xxuda f 000 0|eng||

009      

AR

024    7_

$a 10.3727/000000006783464381 $2 doi

035    __

$a (PubMed)17269439

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Syková, Eva, $d 1944- $7 jn20000710633 $u Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute of Experimental Medicine, ASCR, Prague, Czech Republic

245    10

$a Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury / $c E Sykova, A Homola, R Mazanec, H Lachmann, SL Konradova, P Kobylka, R Padr, J Neuwirth, V Komrska, V Vavra, J Stulik, M Bojar

504    __

$a Literatura

520    9_

$a Stem cell transplants into spinal cord lesions may help to improve regeneration and spinal cord function. Clinical studies are necessary for transferring preclinical findings from animal experiments to humans. We investigated the transplantation of unmanipulated autologous bone marrow in patients with transversal spinal cord injury (SCI) with respect to safety, therapeutic time window, implantation strategy, method of administration, and functional improvement. We report data from 20 patients with complete SCI who received transplants 10 to 467 days postinjury. The follow-up examinations were done at 3, 6, and 12 months after implantation by two independent neurologists using standard neurological classification of SCI, including the ASIA protocol, the Frankel score, the recording of motor and somatosensory evoked potentials, and MRI evaluation of lesion size. We compared intra-arterial (via catheterization of a. vertebralis) versus intravenous administration of all mononuclear cells in groups of acute (10-30 days post-SCI, n=7) and chronic patients (2-17 months postinjury, n=13). Improvement in motor and/or sensory functions was observed within 3 months in 5 of 6 patients with intra-arterial application, in 5 of 7 acute, and in 1 of 13 chronic patients. Our case study shows that the implantation of autologous bone marrow cells appears to be safe, as there have been no complications following implantation to date (11 patients followed up for more than 2 years), but longer follow-ups are required to determine that implantation is definitively safe. Also, we cannot yet confirm that the observed beneficial effects were due to the cell therapy. However, the outcomes following transplantation in acute patients, and in one chronic patient who was in stable condition for several months prior to cell implantation, are promising. It is evident that transplantation within a therapeutic window of 3-4 weeks following injury will play an important role in any type of stem cell SCI treatment. Trials involving a larger population of patients and different cell types are needed before further conclusions can be drawn.

590    __

$a bohemika - dle Pubmed

650    02

$a akutní nemoc $7 D000208

650    02

$a dospělí $7 D000328

650    12

$a transplantace kostní dřeně $x metody $7 D016026

650    02

$a chronická nemoc $7 D002908

650    02

$a elektrofyziologie $7 D004594

650    02

$a ženské pohlaví $7 D005260

650    02

$a následné studie $7 D005500

650    02

$a lidé $7 D006801

650    02

$a magnetická rezonanční tomografie $7 D008279

650    02

$a mužské pohlaví $7 D008297

650    02

$a regenerace nervu $x fyziologie $7 D009416

650    02

$a obnova funkce $x fyziologie $7 D020127

650    02

$a poranění míchy $x chirurgie $x patofyziologie $x patologie $7 D013119

650    02

$a autologní transplantace $7 D014182

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Homola, Aleš $7 xx0278724 $u Center for Cell Therapy and Tissue Repair, Charles University, Prague, Czech Republic; Institute of Experimental Medicine, ASCR, Prague, Czech Republic

700    1_

$a Mazanec, Radim, $d 1959- $7 xx0037204 $u Department of Neurology, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

700    1_

$a Lachmann, Hynek $7 xx0214026 $u Department of Neurology, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

700    1_

$a Langkramer, Šimona $7 _AN029289 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic

700    1_

$a Kobylka, Petr, $d 1949- $7 xx0060254 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic

700    1_

$a Pádr, Radek $7 xx0088068 $u Department of Pediatric Hematology and Oncology, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

700    1_

$a Neuwirth, Jiří, $d 1960- $7 jn20000620249 $u Department of Pediatric Hematology and Oncology, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

700    1_

$a Komrska, Vladimír, $d 1952- $7 xx0081839 $u Department of Imaging Methods, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

700    1_

$a Vávra, Vladimír $7 xx0099529 $u Department of Imaging Methods, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

700    1_

$a Štulík, Jan, $d 1967- $7 nlk20030127573 $u Department of Spondylosurgery, University Hospital Motol, Prague, Czech Republic

700    1_

$a Bojar, Martin, $d 1947- $7 jn19990009805 $u Department of Neurology, University Hospital Motol and 2nd Medical Faculty, Charles University, Prague, Czech Republic

773    0_

$t Cell Transplantation $x 0963-6897 $g Roč. 15, č. 8-9 (2006), s. 675-687 $p Cell Transplant $w MED00001075

773    0_

$p Cell Transplant $g 15(8-9):675-87, 2006 $x 0963-6897

910    __

$a ABA008 $y 3 $z 0

990    __

$a 20131014151634 $b ABA008

991    __

$a 20131015151831 $b ABA008

999    __

$a ok $b bmc $g 997365 $s 831657

BAS    __

$a 3

BMC    __

$a 2006 $b 15 $c 8-9 $d 675-687 $x MED00001075 $i 0963-6897 $m Cell transplantation $n Cell Transplant

GRA    __

$a NR8339 $p MZ0

LZP    __

$a 2013-10/gvbo